Cadence Pharmaceuticals (CADX) Reports a Q3 Loss

November 5, 2009 4:33 PM EST

Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) reports a Q3 loss of $0.23, 4 cents better than the analyst estimate of ($0.27).


Related Categories

Earnings

Stocks Mentioned

CADX 8.70

+0.03 +0.35%
Volume: 312,582
Track CADX


Add Your Comment